A Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)

被引：1
|
作者：
Dispenzieri, Angela
Gertz, Morie Abraham [1 ]
Lacy, Martha Q.
Laumann, Kristina [2 ]
LaPlant, Betsy R.
Kumar, Shaji [1 ]
Buadi, Francis K.
Hayman, Suzanne R. [1 ]
Dingli, David
Hogan, William J.
Ansell, Stephen M. [1 ]
Gastineau, Dennis A.
Inwards, David James [1 ]
Micallef, Ivana N. [1 ]
Porrata, Luis F. [1 ]
Johnston, Patrick B. [1 ]
Litzow, Mark R. [1 ]
Witzig, Thomas E. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Canc Ctr Stat, Rochester, MN USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1337 / 1338
页数：2
相关论文
共 50 条
  • [11] Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma
    N Shah
    P F Thall
    P S Fox
    Q Bashir
    J J Shah
    S Parmar
    P Lin
    P Kebriaei
    Y Nieto
    U R Popat
    C M Hosing
    A Cornelison
    E J Shpall
    R Z Orlowski
    R E Champlin
    M H Qazilbash
    Leukemia, 2015, 29 : 1945 - 1948
  • [12] Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma
    Shah, N.
    Thall, P. F.
    Fox, P. S.
    Bashir, Q.
    Shah, J. J.
    Parmar, S.
    Lin, P.
    Kebriaei, P.
    Nieto, Y.
    Popat, U. R.
    Hosing, C. M.
    Cornelison, A.
    Shpall, E. J.
    Orlowski, R. Z.
    Champlin, R. E.
    Qazilbash, M. H.
    LEUKEMIA, 2015, 29 (09) : 1945 - 1948
  • [13] Melphalan Dose Intensity for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma
    Srour, Samer A.
    Milton, Denai
    Bashir, Qaiser
    Mehta, Rohtesh S.
    Delgado, Ruby
    Rondon, Gabriela
    Nieto, Yago
    Hosing, Chitra M.
    Popat, Uday R.
    Ciurea, Stefan O.
    Patel, Krina
    Lee, Hans C.
    Manasanch, Elisabet
    Thomas, Sheeba
    Weber, Donna
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [14] Engraftment Kinetics after High-Dose Melphalan Autologous Stem Cell Transplant in Patients with Multiple Myeloma
    Bachier-Rodriguez, Lizamarie
    Shah, Gunjan L.
    Knezevic, Andrea
    Devlin, Sean M.
    Maloy, Molly
    Koehne, Guenther
    Chung, David J.
    Landau, Heather
    Giralt, Sergio A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S142 - S143
  • [15] HIGH-DOSE MELPHALAN (HDM) IN MULTIPLE-MYELOMA
    SELBY, P
    POWLES, R
    ROBINSON, B
    VINCENT, M
    MCELWAIN, TJ
    BRITISH JOURNAL OF CANCER, 1984, 50 (02) : 247 - 247
  • [16] Prognostic significance of magnetic resonance imaging (MRI) of bone marrow (BM) in patients with multiple myeloma (MM) undergoing treatment with high-dose melphalan (HDM) and autologous stem cell transplantation (ASCT).
    Anagnostopoulos, Athanasios
    Moulopoulos, Lia A.
    Roussou, Maria
    Kastritis, Efstathios
    Gika, Dimitra
    Bozas, George
    Stefanoudaki, Aikaterini
    Anagnostopouios, Nikolaos
    Vassou, Amalia
    Bourantas, Konstantinos
    Dimopoulos, Meletios A.
    BLOOD, 2006, 108 (11) : 882A - 882A
  • [17] High-dose melphalan (HDM) and autologous stem cell transplantation (ASCT) for myeloma (MM) patients with severe renal failure: Pharmacokinetic study; Correlation between biology and clinics.
    Lioure, B
    Wihlm, J
    Dimitrov, Y
    Abdelkefi, A
    Maloisel, F
    Liu, KL
    Laplace, A
    Moulin, B
    Oberling, F
    BONE MARROW TRANSPLANTATION, 1998, 21 : S202 - S202
  • [18] Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant
    Radujkovic, Aleksandar
    Hundemer, Michael
    Eisenbach, Christoph
    Luft, Thomas
    Penzel, Roland
    Goldschmidt, Hartmut
    Ho, Anthony D.
    Bellos, Frauke
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2967 - 2969
  • [19] BEAM Vs Melphalan Based Conditioning Therapy for Second Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)
    Veeraputhiran, Muthu
    Jain, Tania
    Deol, Abhinav
    Uberti, Joseph
    Kim, Seongho
    Dyson, Gregory
    Abidi, Muneer
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S112 - S113
  • [20] BEAM VS MELPHALAN BASED CONDITIONING THERAPY FOR SECOND AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR MULTIPLE MYELOMA (MM)
    Veeraputhiran, M.
    Jain, T.
    Deol, A.
    Kim, S.
    Dyson, G.
    Uberti, J.
    Abidi, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S347 - S348
12345